Deep Diving into the Development of a PPAR Delta/Gamma Agonist T3D-959 for Alzheimer’s Disease

Time: 4:30 pm
day: Day One

Details:

  • Understanding the PPAR rational in Alzheimer’s Disease
  • Revealing the latest pre-Clinical and early clinical data for T3D-959
  • Showcasing ongoing PIONEER Phase 2 Study with T3D-959

Speakers: